BLOOD-BASED EXOSOMAL A-SYNUCLEIN AGGREGATES AS A QUANTIFIABLE BIOMARKER OF PARKINSON'S DISEASE. NEW AWARD.

University Of Georgia Research Foundation, Inc.

Investigators